Selected research
Market Analysis & Forecast
Global Molecular Biology Software Market Analysis and Forecast 2026-2032
Market perspective
The global Molecular Biology Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Molecular Biology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Molecular Biology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Molecular Biology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Molecular Biology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Molecular Biology Software include QIAGEN, DNASTAR, Inc., SCIEX, SoftGenetics, LLC., Lynnon Biosoft, Thermo Fisher Scientific, PREMIER Biosoft, Biomatters and Benchling, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Molecular Biology Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Molecular Biology Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Molecular Biology Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Molecular Biology Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Molecular Biology Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Molecular Biology Software revenue, projected growth trends, production technology, application and end-user industry.
Molecular Biology Software Segment by Company
QIAGEN
DNASTAR, Inc.
SCIEX
SoftGenetics, LLC.
Lynnon Biosoft
Thermo Fisher Scientific
PREMIER Biosoft
Biomatters
Benchling
CapitalBio Technology
GSL Biotech LLC
Integrated DNA Technologies, Inc. (IDT)
clontech
Molecular Biology Software Segment by Type
View, Edit And Make Plasmid Map
DNA/Protein Database Search and Analysis Tool
Primer Design Tool
Clone Connection Reaction Calculator
Laboratory Math Calculator
Other
Molecular Biology Software Segment by Application
Research
Laboratory
Education
Others
Molecular Biology Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Biology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Biology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Biology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Molecular Biology Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Molecular Biology Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Biology Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- View, Edit And Make Plasmid Map
- DNA/Protein Database Search and Analysis Tool
- Primer Design Tool
- Clone Connection Reaction Calculator
- Laboratory Math Calculator
- Other
Applications
- Research
- Laboratory
- Education
- Others
Companies covered
- QIAGEN
- DNASTAR, Inc.
- SCIEX
- SoftGenetics, LLC.
- Lynnon Biosoft
- Thermo Fisher Scientific
- PREMIER Biosoft
- Biomatters
- Benchling
- CapitalBio Technology
- GSL Biotech LLC
- Integrated DNA Technologies, Inc. (IDT)
- clontech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Molecular Biology Software Market by Type
- 1.2.1 Global Molecular Biology Software Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 View, Edit And Make Plasmid Map
- 1.2.3 DNA/Protein Database Search and Analysis Tool
- 1.2.4 Primer Design Tool
- 1.2.5 Clone Connection Reaction Calculator
- 1.2.6 Laboratory Math Calculator
- 1.2.7 Other
- 1.3 Molecular Biology Software Market by Application
- 1.3.1 Global Molecular Biology Software Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Research
- 1.3.3 Laboratory
- 1.3.4 Education
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Molecular Biology Software Market Dynamics
- 2.1 Molecular Biology Software Industry Trends
- 2.2 Molecular Biology Software Industry Drivers
- 2.3 Molecular Biology Software Industry Opportunities and Challenges
- 2.4 Molecular Biology Software Industry Restraints
3 Global Growth Perspective
- 3.1 Global Molecular Biology Software Market Perspective (2021-2032)
- 3.2 Global Molecular Biology Software Growth Trends by Region
- 3.2.1 Global Molecular Biology Software Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Molecular Biology Software Market Size by Region (2021-2026)
- 3.2.3 Global Molecular Biology Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Molecular Biology Software Revenue by Players
- 4.1.1 Global Molecular Biology Software Revenue by Players (2021-2026)
- 4.1.2 Global Molecular Biology Software Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Molecular Biology Software Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Molecular Biology Software Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Molecular Biology Software Key Players Headquarters & Area Served
- 4.4 Global Molecular Biology Software Players, Product Type & Application
- 4.5 Global Molecular Biology Software Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Molecular Biology Software Market CR5 and HHI
- 4.6.3 2025 Molecular Biology Software Tier 1, Tier 2, and Tier 3
5 Molecular Biology Software Market Size by Type
- 5.1 Global Molecular Biology Software Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Molecular Biology Software Revenue by Type (2021-2032)
- 5.3 Global Molecular Biology Software Revenue Market Share by Type (2021-2032)
6 Molecular Biology Software Market Size by Application
- 6.1 Global Molecular Biology Software Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Molecular Biology Software Revenue by Application (2021-2032)
- 6.3 Global Molecular Biology Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 QIAGEN
- 7.1.1 QIAGEN Company Information
- 7.1.2 QIAGEN Business Overview
- 7.1.3 QIAGEN Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.1.4 QIAGEN Molecular Biology Software Product Portfolio
- 7.1.5 QIAGEN Recent Developments
- 7.2 DNASTAR, Inc.
- 7.2.1 DNASTAR, Inc. Company Information
- 7.2.2 DNASTAR, Inc. Business Overview
- 7.2.3 DNASTAR, Inc. Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.2.4 DNASTAR, Inc. Molecular Biology Software Product Portfolio
- 7.2.5 DNASTAR, Inc. Recent Developments
- 7.3 SCIEX
- 7.3.1 SCIEX Company Information
- 7.3.2 SCIEX Business Overview
- 7.3.3 SCIEX Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.3.4 SCIEX Molecular Biology Software Product Portfolio
- 7.3.5 SCIEX Recent Developments
- 7.4 SoftGenetics, LLC.
- 7.4.1 SoftGenetics, LLC. Company Information
- 7.4.2 SoftGenetics, LLC. Business Overview
- 7.4.3 SoftGenetics, LLC. Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.4.4 SoftGenetics, LLC. Molecular Biology Software Product Portfolio
- 7.4.5 SoftGenetics, LLC. Recent Developments
- 7.5 Lynnon Biosoft
- 7.5.1 Lynnon Biosoft Company Information
- 7.5.2 Lynnon Biosoft Business Overview
- 7.5.3 Lynnon Biosoft Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.5.4 Lynnon Biosoft Molecular Biology Software Product Portfolio
- 7.5.5 Lynnon Biosoft Recent Developments
- 7.6 Thermo Fisher Scientific
- 7.6.1 Thermo Fisher Scientific Company Information
- 7.6.2 Thermo Fisher Scientific Business Overview
- 7.6.3 Thermo Fisher Scientific Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.6.4 Thermo Fisher Scientific Molecular Biology Software Product Portfolio
- 7.6.5 Thermo Fisher Scientific Recent Developments
- 7.7 PREMIER Biosoft
- 7.7.1 PREMIER Biosoft Company Information
- 7.7.2 PREMIER Biosoft Business Overview
- 7.7.3 PREMIER Biosoft Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.7.4 PREMIER Biosoft Molecular Biology Software Product Portfolio
- 7.7.5 PREMIER Biosoft Recent Developments
- 7.8 Biomatters
- 7.8.1 Biomatters Company Information
- 7.8.2 Biomatters Business Overview
- 7.8.3 Biomatters Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.8.4 Biomatters Molecular Biology Software Product Portfolio
- 7.8.5 Biomatters Recent Developments
- 7.9 Benchling
- 7.9.1 Benchling Company Information
- 7.9.2 Benchling Business Overview
- 7.9.3 Benchling Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.9.4 Benchling Molecular Biology Software Product Portfolio
- 7.9.5 Benchling Recent Developments
- 7.10 CapitalBio Technology
- 7.10.1 CapitalBio Technology Company Information
- 7.10.2 CapitalBio Technology Business Overview
- 7.10.3 CapitalBio Technology Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.10.4 CapitalBio Technology Molecular Biology Software Product Portfolio
- 7.10.5 CapitalBio Technology Recent Developments
- 7.11 GSL Biotech LLC
- 7.11.1 GSL Biotech LLC Company Information
- 7.11.2 GSL Biotech LLC Business Overview
- 7.11.3 GSL Biotech LLC Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.11.4 GSL Biotech LLC Molecular Biology Software Product Portfolio
- 7.11.5 GSL Biotech LLC Recent Developments
- 7.12 Integrated DNA Technologies, Inc. (IDT)
- 7.12.1 Integrated DNA Technologies, Inc. (IDT) Company Information
- 7.12.2 Integrated DNA Technologies, Inc. (IDT) Business Overview
- 7.12.3 Integrated DNA Technologies, Inc. (IDT) Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.12.4 Integrated DNA Technologies, Inc. (IDT) Molecular Biology Software Product Portfolio
- 7.12.5 Integrated DNA Technologies, Inc. (IDT) Recent Developments
- 7.13 clontech
- 7.13.1 clontech Company Information
- 7.13.2 clontech Business Overview
- 7.13.3 clontech Molecular Biology Software Revenue and Gross Margin (2021-2026)
- 7.13.4 clontech Molecular Biology Software Product Portfolio
- 7.13.5 clontech Recent Developments
8 North America
- 8.1 North America Molecular Biology Software Revenue (2021-2032)
- 8.2 North America Molecular Biology Software Revenue by Type (2021-2032)
- 8.2.1 North America Molecular Biology Software Revenue by Type (2021-2026)
- 8.2.2 North America Molecular Biology Software Revenue by Type (2027-2032)
- 8.3 North America Molecular Biology Software Revenue Share by Type (2021-2032)
- 8.4 North America Molecular Biology Software Revenue by Application (2021-2032)
- 8.4.1 North America Molecular Biology Software Revenue by Application (2021-2026)
- 8.4.2 North America Molecular Biology Software Revenue by Application (2027-2032)
- 8.5 North America Molecular Biology Software Revenue Share by Application (2021-2032)
- 8.6 North America Molecular Biology Software Revenue by Country
- 8.6.1 North America Molecular Biology Software Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Molecular Biology Software Revenue by Country (2021-2026)
- 8.6.3 North America Molecular Biology Software Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Molecular Biology Software Revenue (2021-2032)
- 9.2 Europe Molecular Biology Software Revenue by Type (2021-2032)
- 9.2.1 Europe Molecular Biology Software Revenue by Type (2021-2026)
- 9.2.2 Europe Molecular Biology Software Revenue by Type (2027-2032)
- 9.3 Europe Molecular Biology Software Revenue Share by Type (2021-2032)
- 9.4 Europe Molecular Biology Software Revenue by Application (2021-2032)
- 9.4.1 Europe Molecular Biology Software Revenue by Application (2021-2026)
- 9.4.2 Europe Molecular Biology Software Revenue by Application (2027-2032)
- 9.5 Europe Molecular Biology Software Revenue Share by Application (2021-2032)
- 9.6 Europe Molecular Biology Software Revenue by Country
- 9.6.1 Europe Molecular Biology Software Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Molecular Biology Software Revenue by Country (2021-2026)
- 9.6.3 Europe Molecular Biology Software Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Molecular Biology Software Revenue (2021-2032)
- 10.2 China Molecular Biology Software Revenue by Type (2021-2032)
- 10.2.1 China Molecular Biology Software Revenue by Type (2021-2026)
- 10.2.2 China Molecular Biology Software Revenue by Type (2027-2032)
- 10.3 China Molecular Biology Software Revenue Share by Type (2021-2032)
- 10.4 China Molecular Biology Software Revenue by Application (2021-2032)
- 10.4.1 China Molecular Biology Software Revenue by Application (2021-2026)
- 10.4.2 China Molecular Biology Software Revenue by Application (2027-2032)
- 10.5 China Molecular Biology Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Molecular Biology Software Revenue (2021-2032)
- 11.2 Asia Molecular Biology Software Revenue by Type (2021-2032)
- 11.2.1 Asia Molecular Biology Software Revenue by Type (2021-2026)
- 11.2.2 Asia Molecular Biology Software Revenue by Type (2027-2032)
- 11.3 Asia Molecular Biology Software Revenue Share by Type (2021-2032)
- 11.4 Asia Molecular Biology Software Revenue by Application (2021-2032)
- 11.4.1 Asia Molecular Biology Software Revenue by Application (2021-2026)
- 11.4.2 Asia Molecular Biology Software Revenue by Application (2027-2032)
- 11.5 Asia Molecular Biology Software Revenue Share by Application (2021-2032)
- 11.6 Asia Molecular Biology Software Revenue by Country
- 11.6.1 Asia Molecular Biology Software Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Molecular Biology Software Revenue by Country (2021-2026)
- 11.6.3 Asia Molecular Biology Software Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Molecular Biology Software Revenue (2021-2032)
- 12.2 SAMEA Molecular Biology Software Revenue by Type (2021-2032)
- 12.2.1 SAMEA Molecular Biology Software Revenue by Type (2021-2026)
- 12.2.2 SAMEA Molecular Biology Software Revenue by Type (2027-2032)
- 12.3 SAMEA Molecular Biology Software Revenue Share by Type (2021-2032)
- 12.4 SAMEA Molecular Biology Software Revenue by Application (2021-2032)
- 12.4.1 SAMEA Molecular Biology Software Revenue by Application (2021-2026)
- 12.4.2 SAMEA Molecular Biology Software Revenue by Application (2027-2032)
- 12.5 SAMEA Molecular Biology Software Revenue Share by Application (2021-2032)
- 12.6 SAMEA Molecular Biology Software Revenue by Country
- 12.6.1 SAMEA Molecular Biology Software Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Molecular Biology Software Revenue by Country (2021-2026)
- 12.6.3 SAMEA Molecular Biology Software Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst